Prisys has been helping global biomedical researchers, with its unique Nonhuman Primate (NHP) CRO and technology platform, on the preclinical-to-clinical transformation of new drug candidates since 2012. With the newly opening of the industrial scale NHP research center in Shanghai, Prisys offers broad services and research capabilities such as:
NHP Pharmacology; PK/PD/ADME; Safety Evaluation; Translation Research; Medical Devices; Respiratory Disease Research; Metabolic Disease Research; Hematological Disease Research; Immunological Disease Research; Ophthalmic Disease Research; Neurology Research; Co-develop;